LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX)

Q: What does CUSIP 528872302 represent in this 13F holders report?

CUSIP 528872302 is the security identifier for LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in Q1 2020?

107 institutional investors reported LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share for Q1 2020. Use the holders table for investor-level position and value details.

CUSIP: 528872302

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 427,442,892
Total 13F shares: 104,815,254
Share change: -2,371,359
Total reported value: $204,388,139
Put/Call ratio: 57%
Price per share: $1.95
Number of holders: 107
Value change: -$17,170,082
Number of buys: 55
Number of sells: 50

Quarterly Holders Quick Answers

What is CUSIP 528872302?
CUSIP 528872302 identifies LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 528872302:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Artal Group S.A.	13F	Company	14%	60,240,864	$249,999,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	2.9%	12,559,494	$52,122,000	—	31 Dec 2019	13F
Ulys, L.L.C.	13F	Individual	1%	4,321,214	$17,933,000	—	31 Dec 2019	13F
BlackRock Finance, Inc.	13F	Company	0.95%	4,054,634	$16,828,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	0.7%	2,976,003	$12,351,000	—	31 Dec 2019	13F
Boxer Capital, LLC	13F	Company	0.65%	2,775,000	$11,516,000	—	31 Dec 2019	13F
NEA Management Company, LLC	13F	Company	0.56%	2,382,286	$9,886,000	—	31 Dec 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.31%	1,309,722	$5,435,000	—	31 Dec 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.28%	1,203,178	$4,993,000	—	31 Dec 2019	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.26%	1,111,648	$4,613,340	—	31 Dec 2019	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.23%	990,419	$4,110,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	0.21%	896,170	$3,719,000	—	31 Dec 2019	13F
MARSHALL WACE, LLP	13F	Company	0.2%	850,928	$3,531,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.19%	794,876	$3,299,000	—	31 Dec 2019	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.16%	699,376	$2,902,000	—	31 Dec 2019	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.16%	692,603	$2,874,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.16%	670,137	$2,781,000	—	31 Dec 2019	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.14%	588,446	$2,442,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.12%	533,543	$2,214,000	—	31 Dec 2019	13F
Portolan Capital Management, LLC	13F	Company	0.11%	471,015	$1,955,000	—	31 Dec 2019	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.1%	443,962	$1,842,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.1%	442,146	$1,835,000	—	31 Dec 2019	13F
PINNACLE ASSOCIATES LTD	13F	Company	0.09%	399,374	$1,657,000	—	31 Dec 2019	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.09%	369,243	$1,532,000	—	31 Dec 2019	13F
WEDBUSH SECURITIES INC	13F	Company	0.09%	367,662	$1,526,000	—	31 Dec 2019	13F
Spark Investment Management LLC	13F	Company	0.08%	363,100	$1,506,000	—	31 Dec 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.07%	318,812	$1,323,000	—	31 Dec 2019	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.07%	289,716	$1,202,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.06%	262,850	$1,091,000	—	31 Dec 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.05%	193,375	$803,000	—	31 Dec 2019	13F
BARROW HANLEY MEWHINNEY & STRAUSS LLC	13F	Company	0.04%	180,194	$748,000	—	31 Dec 2019	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.04%	179,481	$745,000	—	31 Dec 2019	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.04%	164,948	$685,000	—	31 Dec 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	0.04%	162,971	$676,000	—	31 Dec 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.04%	158,626	$658,000	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.03%	144,392	$599,000	—	31 Dec 2019	13F
AXA S.A.	13F	Company	0.03%	134,702	$559,000	—	31 Dec 2019	13F
VIRTUS ADVISERS, LLC	13F	Company	0.03%	131,286	$545,000	—	31 Dec 2019	13F
STRS OHIO	13F	Company	0.03%	128,900	$534,000	—	31 Dec 2019	13F
FEDERATED HERMES, INC.	13F	Company	0.03%	112,397	$466,000	—	31 Dec 2019	13F
Leap Investments LP	13F	Company	0.03%	108,399	$450,000	—	31 Dec 2019	13F
Squarepoint Ops LLC	13F	Company	0.02%	105,889	$439,000	—	31 Dec 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.02%	103,905	$431,000	—	31 Dec 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.02%	101,456	$420,000	—	31 Dec 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.02%	98,503	$409,000	—	31 Dec 2019	13F
Swiss National Bank	13F	Company	0.02%	88,614	$368,000	—	31 Dec 2019	13F
AMP Capital Investors Ltd	13F	Company	0.02%	88,400	$366,000	—	31 Dec 2019	13F
Birchview Capital, LP	13F	Company	0.02%	80,000	$332,000	—	31 Dec 2019	13F
STIFEL FINANCIAL CORP	13F	Company	0.02%	72,135	$298,000	—	31 Dec 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.02%	71,897	$298,000	—	31 Dec 2019	13F

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX) as of Q1 2020

As of 31 Mar 2020, LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX) was held by 107 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 104,815,254 shares. The largest 10 holders included Artal Group S.A., FMR LLC, Ulys, L.L.C., BlackRock Inc., VANGUARD GROUP INC, NEA Management Company, LLC, RENAISSANCE TECHNOLOGIES LLC, AQR CAPITAL MANAGEMENT LLC, MARSHALL WACE, LLP, and PICTET ASSET MANAGEMENT LTD. This page lists 107 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

110

Q1 2020 holders

107

Holder diff

-3

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.